Transactions With Shares And Linked Securities In H. Lundbeck A/S Made By Executives And Their Closely Associated Parties
Published: Aug 28, 2017
Valby, Denmark, 2017-08-28 17:32 CEST (GLOBE NEWSWIRE) -- Valby, Denmark, 28 August 2017 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck.
Details of the person discharging managerial responsibilities /
person closely associated
|2.||Reason for the notification|
|a)||Position/status||Board member (elected by the employees)|
|b)||Initial notification/Amendment||Initial notification|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|a)||Name||H. Lundbeck A/S|
|4.||Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted|
Description of the financial
instrument, type of instrument
|b)||Nature of the transaction||Sale of shares|
|c)||Price(s) and volume(s)||Price(s)||Volume(s)|
- Aggregated volume
|e)||Date of the transaction||2017-08-28|
|f)||Place of the transaction||NASDAQ Copenhagen XCSE|
Persons under an obligation to report are defined as members of the Executive Management, members of the Board of Directors and other executives of H. Lundbeck A/S and persons/entities closely associated to them.
Closely associated persons/entities means inter alia:
- spouse or cohabitant
- dependent children
- legal entities in which the executive has a controlling influence.
|Palle Holm Olesen||Mads Kronborg|
|Vice President, Investor Relations||Senior Director, Corp. Communication|
|+45 30 83 24 26||+45 36 43 40 00|
H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company specialized in psychiatric and neurological disorders. For more than 70 years, we have been at the forefront of research within neuroscience. Our key areas of focus are Alzheimer's disease, depression, Parkinson's disease and schizophrenia.
Our approximately 5,000 employees in 55 countries are engaged in the entire value chain throughout research, development, manufacturing, marketing and sales. Our pipeline consists of several late-stage development programmes and our products are available in more than 100 countries. We have production facilities in Denmark, France and Italy. Lundbeck generated revenue of DKK 15.6 billion in 2016 (EUR 2.1 billion; USD 2.2 billion).
For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck.